Health
Diabetes drug can treat and reverse heart failure and reduce – EurekAlert
Mount Sinai clinical trial results could help lead to FDA approval
Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.
Their clinical trial showed that this medication can improve the heart’s size, shape, and function, leading to better exercise capacity and quality of life, which will reduce hospitalizations for heart failure patients. The results were presented on Friday, November 13, at the American…
-
Noosa News20 hours ago‘Just want to know he’s safe’: Family’s German Shepherd asleep in back of stolen ute
-
Noosa News24 hours agoQueensland Cross-Border Commissioner and former police union boss Ian Leavers found dead at Brisbane home
-
Noosa News23 hours agoLogan man Umar Al Enizi cleared of murder after Browns Plains road rage incident in 2021
-
Noosa News20 hours agoDriver acquitted of murder over lengthy road-rage chase